CD274 and metabolic dysfunction-associated steatohepatitis: As losartan only slightly affect hepatosteatosis, our results suggest that liver fibrosis maybe a more relevant explanation of the modest response of NASH-induced HCC to PD-(L)1 blockers (12, –14).